BARIUM SULFATE, USP IN SUSPENSION— 510(k) K800459

Substantially Equivalent

Central Pharmaceuticals, Inc.

FDA 510(k) clearance K800459 for BARIUM SULFATE, USP IN SUSPENSION, Substantially Equivalent on 1980-05-30. Applicant: Central Pharmaceuticals, Inc..

Clearance details

Applicant
Central Pharmaceuticals, Inc.
Product code
Code KTA
Advisory panel
Unknown
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mchenry, IL, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.